Senti Biosciences, Inc.

Senti Biosciences, Inc. (Nasdaq: SNTI) is a South San Francisco-based synthetic biology company that entered the public markets through a de-SPAC merger with Dynamics Special Purpose Corp, a blank-check vehicle sponsored by Dynamics Capital Management that completed its IPO in 2021. Senti filed its S-1 registration statement on June 28, 2022, shortly after the business combination closed, formalizing its listing on Nasdaq under the ticker SNTI. The company operates in the biotechnology sector, developing programmable gene circuit technologies aimed at oncology and other therapeutic areas. For full filing history, deal terms, and ongoing company data on SNTI and hundreds of other de-SPAC transactions, sign up for complete access at SpacDesk.